Hanson & Doremus Investment Management Bristol Myers Squibb CO Transaction History

Hanson & Doremus Investment Management

$748 Million
Q2 2025

A detailed history of Hanson & Doremus Investment Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 18,188 shares of BMY stock, worth $796,634. This represents 0.11% of its overall portfolio holdings.

Number of Shares

18,188

Previous 18,897 3.75%

Holding current value

$796,634

Previous $1.15 Million 26.97%

% of portfolio

0.11%

Previous 0.17%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	SELL	$44.12 - $59.6 $31,281 - $42,256	-709 Reduced 3.75%	18,188 $842,000
Q1 2025 Apr 17, 2025	SELL	$53.9 - $63.11 $25,710 - $30,103	-477 Reduced 2.46%	18,897 $1.15 Million
Q4 2024 Jan 23, 2025	SELL	$51.92 - $59.94 $27,881 - $32,187	-537 Reduced 2.7%	19,374 $1.1 Million
Q3 2024 Oct 17, 2024	SELL	$39.66 - $51.75 $135,597 - $176,933	-3,419 Reduced 14.65%	19,911 $1.03 Million
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $267,743 - $352,489	-6,652 Reduced 22.19%	23,330 $968,000
Q1 2024 Apr 22, 2024	SELL	$47.98 - $54.4 $162,604 - $184,361	-3,389 Reduced 10.16%	29,982 $1.63 Million
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $90,463 - $107,948	-1,866 Reduced 5.3%	33,371 $1.71 Million
Q3 2023 Oct 24, 2023	SELL	$57.89 - $64.73 $66,805 - $74,698	-1,154 Reduced 3.17%	35,237 $2.05 Million
Q2 2023 Jul 18, 2023	BUY	$63.71 - $70.74 $85,498 - $94,933	1,342 Added 3.83%	36,391 $2.33 Million
Q1 2023 Apr 18, 2023	SELL	$65.71 - $74.53 $149,884 - $170,002	-2,281 Reduced 6.11%	35,049 $2.43 Million
Q4 2022 Jan 18, 2023	BUY	$68.48 - $81.09 $262,552 - $310,899	3,834 Added 11.45%	37,330 $2.69 Million
Q3 2022 Oct 20, 2022	SELL	$0.13 - $76.84 $77 - $45,873	-597 Reduced 1.75%	33,496 $2.38 Million
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $36,310 - $39,990	-500 Reduced 1.45%	34,093 $2.63 Million
Q1 2022 Apr 22, 2022	SELL	$61.48 - $73.72 $5,594 - $6,708	-91 Reduced 0.26%	34,593 $2.53 Million
Q4 2021 Jan 20, 2022	BUY	$53.63 - $62.52 $22,417 - $26,133	418 Added 1.22%	34,684 $2.16 Million
Q3 2021 Oct 21, 2021	SELL	$59.17 - $69.31 $312,180 - $365,679	-5,276 Reduced 13.34%	34,266 $2.03 Million
Q2 2021 Jul 22, 2021	BUY	$61.91 - $67.42 $126,853 - $138,143	2,049 Added 5.47%	39,542 $2.38 Million
Q1 2021 May 03, 2021	SELL	$59.34 - $66.74 $150,189 - $168,918	-2,531 Reduced 6.32%	37,493 $2.37 Million
Q4 2020 Feb 01, 2021	BUY	$57.74 - $65.43 $27,830 - $31,537	482 Added 1.22%	40,024 $2.48 Million
Q3 2020 Oct 19, 2020	BUY	$57.43 - $63.64 $976 - $1,081	17 Added 0.04%	39,542 $2.38 Million
Q2 2020 Jul 17, 2020	SELL	$54.82 - $64.09 $133,651 - $156,251	-2,438 Reduced 5.81%	39,525 $2.32 Million
Q1 2020 Apr 24, 2020	BUY	$46.4 - $67.43 $76,003 - $110,450	1,638 Added 4.06%	41,963 $2.34 Million
Q4 2019 Jan 16, 2020	BUY	$49.21 - $64.19 $162,245 - $211,634	3,297 Added 8.9%	40,325 $2.59 Million
Q3 2019 Oct 18, 2019	BUY	$42.77 - $50.71 $141,739 - $168,052	3,314 Added 9.83%	37,028 $1.88 Million
Q2 2019 Jul 18, 2019	BUY	$44.62 - $49.34 $15,527 - $17,170	348 Added 1.04%	33,714 $1.53 Million
Q1 2019 Apr 23, 2019	BUY	$45.12 - $53.8 $11,911 - $14,203	264 Added 0.8%	33,366 $0
Q4 2018 Jan 31, 2019	SELL	$48.76 - $63.23 $28,719 - $37,242	-589 Reduced 1.75%	33,102 $1.72 Million
Q3 2018 Oct 24, 2018	SELL	$55.19 - $62.25 $27,815 - $31,374	-504 Reduced 1.47%	33,691 $0
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $92,823 - $115,694	-1,837 Reduced 5.1%	34,195 $1.89 Million
Q1 2018 May 10, 2018	BUY	$59.92 - $68.98 $98,688 - $113,610	1,647 Added 4.79%	36,032 $2.28 Million
Q4 2017 Jan 25, 2018	SELL	$59.94 - $65.35 $8,811 - $9,606	-147 Reduced 0.43%	34,385 $2.11 Million
Q3 2017 Oct 26, 2017	BUY	$55.23 - $63.74 $1.91 Million - $2.2 Million	34,532	34,532 $0

Others Institutions Holding BMY

# of Institutions

2,672

Shares Held

1.64B

Call Options Held

22.4M

Put Options Held

25.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $93.1B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.

Account

Hanson & Doremus Investment Management Bristol Myers Squibb CO Transaction History